SEC Filings

Filing date Form Description Filing Group View
D
Other
View HTML
D
Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
6-K/A

Amendment to a previously filed 6-K

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML

Data provided by Kaleidoscope.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

Read More >
D-PLEX100

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >
D-PLEX1000

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >